Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48,877	30,350	24,021	29,238	20,282	15,100
Market Cap Growth	55.78%	26.35%	-17.84%	44.16%	34.32%	17.60%
Enterprise Value	48,926	30,296	24,278	29,564	19,873	14,639
Last Close Price	369.96	235.31	191.41	237.65	169.58	129.97
PS Ratio	15.01	13.50	13.14	28.18	24.02	30.64
PB Ratio	208.46	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	208.97	452.40	-	-	34.48	14.86
P/FCF Ratio	220.80	-	572.67	-	-	-
P/OCF Ratio	183.84	-	230.62	-	-	-
EV/Sales Ratio	15.24	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	221.02	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	5.74%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.09%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.45%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q